The Global Laboratory Initiative (GLI) is a network of international partners dedicated to accelerating and expanding access to quality assured laboratory services in response to the diagnostic challenges of TB, notably HIV-associated and drug-resistant TB. The GLI provides a focus for TB within the framework of a multi-faceted yet integrated approach to laboratory capacity strengthening.

Featured GLI Products

Practical Guide to Implementation of Truenat tests
PDF icon Download (5.02 MB)
Practical implementation of LF-LAM for detection of active TB in people living with HIV
PDF icon Download (3.71 MB)
GLI TB Laboratory Safety Handbook
PDF icon Download (7.94 MB)

Information Notes

Practical considerations for implementation of the Abbott RealTime MTB and Abbott RealTime MTB RIF/INH tests
PDF icon Download (151.53 KB)
Practical considerations for implementation of the BD MAX MDR-TB test
PDF icon Download (136.42 KB)
Practical considerations for implementation of the Roche cobas MTB and cobas MTB-RIF/INH assays
PDF icon Download (137.07 KB)
Practical considerations for implementation of the Bruker-Hain Lifesciences FluoroType MTB and FluoroType MTBDR
PDF icon Download (140.23 KB)
Practical considerations for implementation of the Cepheid Xpert MTB/XDR test
PDF icon Download (138.17 KB)
Practical considerations for implementation of the Nipro Genoscholar PZA-TB II assay
PDF icon Download (137.25 KB)
Practical considerations for implementation of the loop-mediated isothermal amplification (TB-LAMP) test
PDF icon Download (428.52 KB)

GLI Working Group Secretariat
Global TB Programme
World Health Organization
Geneva, Switzerland
Email: gli_secretariat@who.int